Investing

Investment Purchases

Vertex Pharmaceuticals Investment Purchases increased by 103.8% to $2.51B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.2%, from $1.65B to $2.51B. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows an upward trend with a 86.5% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase may indicate a strategy to earn interest on excess cash, while a decrease may suggest a need for cash for operations or debt repayment.

Detailed definition

This metric captures the cash outflow for the purchase of marketable securities, such as stocks, bonds, or other financi...

Peer comparison

Standard for large-cap companies with significant cash reserves; peers manage these portfolios to balance liquidity needs with yield generation.

Metric ID: purchases_of_investments

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$118.00M$208.30M$80.40M$117.10M$110.80M$189.90M$274.90M$1.82B$574.20M$407.20M$988.50M$2.60B$1.30B$1.38B$2.16B$1.65B$2.17B$1.35B$1.23B$2.51B
QoQ Change+76.5%-61.4%+45.6%-5.4%+71.4%+44.8%+560.8%-68.4%-29.1%+142.8%+162.9%-50.1%+6.8%+55.9%-23.7%+31.9%-38.1%-8.5%+103.8%
YoY Change-6.1%-8.8%+241.9%>999%+418.2%+114.4%+259.6%+43.0%+125.8%+240.0%+118.4%-36.6%+67.6%-2.8%-43.0%+52.2%
Range$80.40M$2.60B
CAGR+90.3%
Avg YoY Growth+189.7%
Median YoY Growth+91.0%

Frequently Asked Questions

What is Vertex Pharmaceuticals's investment purchases?
Vertex Pharmaceuticals (VRTX) reported investment purchases of $2.51B in Q1 2026.
How has Vertex Pharmaceuticals's investment purchases changed year-over-year?
Vertex Pharmaceuticals's investment purchases increased by 52.2% year-over-year, from $1.65B to $2.51B.
What is the long-term trend for Vertex Pharmaceuticals's investment purchases?
Over 4 years (2021 to 2025), Vertex Pharmaceuticals's investment purchases has grown at a 86.5% compound annual growth rate (CAGR), from $528.20M to $6.40B.
What does investment purchases mean?
Cash used to buy financial assets or securities.